<b>Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project </b><b>HOPE

Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—

Published:2014 Issue:6 Volume:35 Page:407-412
ISSN:0388-6107
Container-title:Biomedical Research
language:en
Short-container-title:Biomed. Res.

Author:

YAMAGUCHI Ken¹²,URAKAMI Kenichi³,OHSHIMA Keiichi⁴,MOCHIZUKI Tohru⁴,AKIYAMA Yasuto⁵,UESAKA Katsuhiko²,NAKAJIMA Takashi²,TAKAHASHI Mitsuru²,TAMAI Sunao²,KUSUHARA Masatoshi⁶⁷

Affiliation:

1. Shizuoka Cancer Center Research Institute

2. Shizuoka Cancer Center Hospital

3. Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute

4. Medical Genetics Division, Shizuoka Cancer Center Research Institute

5. Immunotherapy Division, Shizuoka Cancer Center Research Institute

6. Drug Discovery & Development Division, Shizuoka Cancer Center Research Institute

7. Regional Resources Division, Shizuoka Cancer Center Research Institute

Publisher

Biomedical Research Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference21 articles.

1. 1 Beadling C, Neff TL, Heinrich MC, Rhodes K, Thornton M, Leamon J, Andersen M and Corless CL (2013) Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping. J Mol Diagn 15, 171–176.

2. 2 COSMIC Cell Lines Project (2014) http://cancer.sanger.ac.uk/cancergenome/projects/cell_lines/

3. 3 Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, BeareD, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR and Futreal PA (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39 (Database issue), D945–950.

4. 4 Frampton GM, Fichtenholtz A, Otto GA, Wang K, Downing SR, He J, Schnall-Levin M, White J, Sanford EM, An P, Sun J, Juhn F, Brennan K, Iwanik K, Maillet A, Buell J, White E, Zhao M, Balasubramanian S, Terzic S, Richards T, Banning V, Garcia L, Mahoney K, Zwirko Z, Donahue A, Beltran H, Mosquera JM, Rubin MA, Dogan S, Hedvat CV, Berger MF, Pusztai L, Lechner M, Boshoff C, Jarosz M, Vietz C, Parker A, Miller VA, Ross JS, Curran J, Cronin, Stephens PJ, Lipson D and Yelensky R (2013) Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 31, 1023–1031.

5. 5 Garraway LA and Lander ES (2013) Lessons from the cancer genome. Cell 153, 17–37.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the FIGO2023 staging system on endometrial cancer in Japan: differences between next-generation sequencing and simplified surrogate marker analysis;Japanese Journal of Clinical Oncology;2024-08-24

2. The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasis;Surgery Today;2024-07-31

3. Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer;Gastric Cancer;2024-05-14

4. Risk factors for lateral lymph node metastasis based on the molecular profiling of rectal cancer;Colorectal Disease;2023-11-29

5. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors HarboringKITExon 11 557–558 Deletion Mutations;Cancer Research Communications;2023-04-24